MyMelanomaTeam

That's a really important and understandably worrying question. Both Opdivo (nivolumab) and Yervoy (ipilimumab) carry known risks of embryo-fetal toxicity, meaning they can potentially harm an unborn baby. This is a serious concern that needs immediate attention from your oncologist and OB team together. As for whether this Show Full Answer

That's a really important and understandably worrying question. Both Opdivo (nivolumab) and Yervoy (ipilimumab) carry known risks of embryo-fetal toxicity, meaning they can potentially harm an unborn baby. This is a serious concern that needs immediate attention from your oncologist and OB team together. As for whether this makes your melanoma more aggressive or immunotherapy less effective going forward — that's not something that can be answered here with confidence. It really depends on individual factors like your melanoma's stage, genetics, and how your body has responded so far.

What's most important right now is to:

- Contact your oncologist immediately if you haven't already disclosed the pregnancy
- Ask specifically about how the treatments may have affected both you and the baby
- Request a full reassessment of your treatment plan given the circumstances

Please don't wait on this — your care team needs to know as soon as possible to help you make the safest decisions for both you and your baby.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Treatments

Opdivo

Yervoy